Oxford Biodynamics Announces US Launch of its 94% Accurate EpiSwitch® Prostate Screening Blood Test to Men With Prostate Cancer Risk
EpiSwitch Prostate Screening is designed to run alongside a standard PSA test PSE boosts PSA predictive accuracy from 55% to 94%1 for determining the presence or absence of prostate...
Source: marketscreener.com